Compare · DVA vs QIPT
DVA vs QIPT
Side-by-side comparison of DaVita Inc. (DVA) and Quipt Home Medical Corp. (QIPT): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DVA and QIPT operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- DVA is the larger of the two at $10.01B, about 60.0x QIPT ($166.8M).
- DVA has hit the wire 3 times in the past 4 weeks while QIPT has been quiet.
- DVA has more recent analyst coverage (12 ratings vs 6 for QIPT).
- Company
- DaVita Inc.
- Quipt Home Medical Corp.
- Price
- $151.81-2.06%
- $3.65+0.00%
- Market cap
- $10.01B
- $166.8M
- 1M return
- -2.17%
- -
- 1Y return
- +8.05%
- -
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 3
- 0
- Recent ratings
- 12
- 6
DaVita Inc.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services; vascular access services; clinical research programs; physician services; and comprehensive care services. As of December 31, 2020, it provided dialysis and administrative services in the United States through a network of 2,816 outpatient dialysis centers serving approximately 204,200 patients; and operated 321 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 36,700 patients. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Quipt Home Medical Corp.
Quipt Home Medical Corp. provides in-home monitoring equipment and disease management services includes end-to-end respiratory solutions for patients in the United States. It offers daily and ambulatory aides; power mobility equipment; BiPAP and CPAP machines, nebulizers, oxygen concentrators, and ventilators; oxygen therapy; sleep apnea and PAP treatment equipment; and home ventilator equipment, as well as rents respiratory equipment. The company also offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.
Latest DVA
- SEC Form DEFA14A filed by DaVita Inc.
- SEC Form DEF 14A filed by DaVita Inc.
- DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call
- Amendment: SEC Form SCHEDULE 13G/A filed by DaVita Inc.
- DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement
- Director Arway Pamela M was granted 332 shares, increasing direct ownership by 1% to 26,695 units (SEC Form 4)
- Director Desoer Barbara J was granted 332 shares (SEC Form 4)
- Chief Operating Officer, DKC Maughan David Paul was granted 5,308 shares and covered exercise/tax liability with 13,107 shares, decreasing direct ownership by 6% to 114,467 units (SEC Form 4)
- Director Yale Phyllis R was granted 332 shares, increasing direct ownership by 2% to 14,313 units (SEC Form 4)
- Chief Executive Officer Rodriguez Javier was granted 20,900 shares, increasing direct ownership by 2% to 909,815 units (SEC Form 4)
Latest QIPT
- SEC Form 15-12G filed by Quipt Home Medical Corp.
- Amendment: SEC Form SCHEDULE 13D/A filed by Quipt Home Medical Corp.
- Director Wessel Brian Joseph returned $787,411 worth of shares to the company (215,729 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- Chief Accounting Officer Roehrig Thomas returned $631,450 worth of shares to the company (173,000 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- Chief Compliance Officer Miles Mark Alan returned $401,500 worth of shares to the company (110,000 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- Director Greenberg Mark Alan returned $1,589,418 worth of shares to the company (435,457 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- Exec. VP Operations Gamble Patrick Dennis returned $219,208 worth of shares to the company (60,057 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- President/CEO Crawford Gregory John returned $16,755,427 worth of shares to the company (4,590,528 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- Director Carter Kevin A. returned $734,234 worth of shares to the company (201,160 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- Exec. VP Operations Bachelder David returned $80,869 worth of shares to the company (22,156 units at $3.65), closing all direct ownership in the company (SEC Form 4)